Axel F. GrotheyMD
Axel Grothey is a Professor of Oncology and Consultant in the Division of Medical Oncology in the Department of Oncology at the Mayo Clinic in Rochester, MN. He is the Vice Chair of the North Central Cancer Treatment Group (NCCTG) and the co-chair of the NCCTG GI committee.
After receiving his medical degree from Ruhr-University Bochum in Germany, Dr. Grothey completed his residency in internal medicine at the West-German Tumor Center at the University of Essen. He also completed residencies in pathology and internal medicine at prestigious universities in Germany and was awarded a fellowship in the Department of Hematology-Oncology at the University of Bochum. Subsequently, Dr. Grothey was awarded a postdoctoral research fellowship to address the effect of kinase-mediated signaling on the actin cytoskeleton and phenotypic properties of cancer cells at the MD Anderson Cancer Center at the University of Texas.
Dr. Grothey is a member of the Association of German Internists, the American Association of Cancer Research, the European Association for Cancer Research, the American Society for Cell Biology, the American Society of Clinical Oncology, and the European Society for Medical Oncology. He serves on the review board of numerous professional journals. In addition, he is widely published in many peer-reviewed journals. Dr. Grothey’s major areas of clinical interest are GI malignancies, in particular, colorectal cancer, unknown primaries, and neuroendocrine tumors.